Published on 20 Jun 2024 on GuruFocus.com · via Yahoo Finance
Jonathan Slonin, Chief Medical Officer of Pacira BioSciences Inc (NASDAQ:PCRX), executed a sale of 5,012 shares of the company on June 11, 2024, as reported in a recent SEC Filing. Following this transaction, the insider now owns 98,869.475 shares of the company.
Warning! GuruFocus has detected 3 Warning Sign with PCRX.
Pacira BioSciences Inc (NASDAQ:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company primarily engages in the development of non-opioid products for the management of post-surgical pain.